Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
ConditionChronic Liver Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssociation HGE CHU Bordeaux Sud
About this trial
The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
chronic hepatitis C
chronic hepatitis B
alcohol liver disease
non alcoholic liver disease
Disqualifiers
ascitis
Trial population
all consecutive patients with an age over eighteen and chronic liver disease
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
10,000 Participants
are grouped into 1 trial groupGroup A: Chronic liver disease
Trial outcomes
Primary outcomes
1
Overall survival
Time frame
20 yearsSecondary outcomes
1
Survival without liver complications
Time frame
20 yearsOther outcomes
1
Survival without liver transplantation
Time frame
20 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov